A path forward in the debate over health impacts of endocrine disrupting chemicals
暂无分享,去创建一个
Taisen Iguchi | Laura N. Vandenberg | Jorma Toppari | Andreas Kortenkamp | Åke Bergman | Poul Bjerregaard | Susan Jobling | Laura N Vandenberg | R Thomas Zoeller | Karen A Kidd | J. Toppari | N. Skakkebaek | R. Zoeller | A. Kortenkamp | K. Kidd | L. Vandenberg | A. Bergman | S. Jobling | G. Becher | P. Bjerregaard | R. Bornman | I. Brandt | T. Iguchi | Georg Becher | Niels E Skakkebaek | Riana Bornman | Ingvar Brandt | R. Zoeller | Karen A. Kidd | Niels E. Skakkebaek | Niels E Skakkebaek | N. E. Skakkebaek
[1] L. Giudice,et al. State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .
[2] A. B. Hill,et al. "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .
[3] R. Zoeller,et al. Polybrominated diphenyl ether (DE-71) interferes with thyroid hormone action independent of effects on circulating levels of thyroid hormone in male rats. , 2014, Endocrinology.
[4] Julie E Goodman,et al. Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. , 2014, Regulatory toxicology and pharmacology : RTP.
[5] Anna Beronius,et al. Facilitating the use of non‐standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting , 2014, Journal of applied toxicology : JAT.
[6] John R. Bucher,et al. Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.
[7] Laura N. Vandenberg,et al. Low-dose effects of hormones and endocrine disruptors. , 2014, Vitamins and hormones.
[8] D. Dietrich,et al. Endocrine disruption: fact or urban legend? , 2013, Toxicology letters.
[9] P. Hof,et al. Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. , 2013, Andrology.
[10] Christopher J Borgert,et al. Potency matters: thresholds govern endocrine activity. , 2013, Regulatory toxicology and pharmacology : RTP.
[11] Sharon Munn,et al. Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. , 2013, Chemosphere.
[12] K. Coser,et al. Expressomal approach for comprehensive analysis and visualization of ligand sensitivities of xenoestrogen responsive genes , 2013, Proceedings of the National Academy of Sciences.
[13] G. B. Gori,et al. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. , 2013, Chemico-biological interactions.
[14] J. Bucher,et al. A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program. , 2013, Reproductive toxicology.
[15] G. B. Gori,et al. Open letter to the European commission: scientifically unfounded precaution drives European commission’s recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles , 2013, Archives of Toxicology.
[16] Laura N. Vandenberg,et al. Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors , 2013, Environmental Health.
[17] Laura N. Vandenberg,et al. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. , 2013, Reproductive toxicology.
[18] T. Woodruff,et al. Instruments for Assessing Risk of Bias and Other Methodological Criteria of Published Animal Studies: A Systematic Review , 2013, Environmental health perspectives.
[19] Julie E Goodman,et al. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? , 2012, Regulatory toxicology and pharmacology : RTP.
[20] J. Bucher,et al. Consortium-Based Science: The NIEHS’s Multipronged, Collaborative Approach to Assessing the Health Effects of Bisphenol A , 2012, Environmental health perspectives.
[21] Andreas Kortenkamp,et al. Response to A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” by Rhomberg and colleagues – letter to the editor , 2012, Critical reviews in toxicology.
[22] T J Woodruff,et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. , 2012, Endocrinology.
[23] P. Gluckman,et al. Developmental origins of non-communicable disease: Implications for research and public health , 2012, Environmental Health.
[24] G. Metz,et al. The secret language of destiny: stress imprinting and transgenerational origins of disease , 2012, Front. Gene..
[25] Julie E. Goodman,et al. A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” , 2012, Critical reviews in toxicology.
[26] Laura N. Vandenberg,et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.
[27] L S McCarty,et al. The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. , 2012, Regulatory toxicology and pharmacology : RTP.
[28] Richard David Evans,et al. State of the art assessment of endocrine disruptors: Final Report , 2011 .
[29] C. Rosenfeld,et al. Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: a review. , 2011, Seminars in reproductive medicine.
[30] Patrice Sutton,et al. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.
[31] Stuart Tobet,et al. Cooperation of sex chromosomal genes and endocrine influences for hypothalamic sexual differentiation , 2011, Frontiers in Neuroendocrinology.
[32] H. Mazeh,et al. Endocrinology, Adult and Pediatric, 6th edition , 2011 .
[33] R. Becker,et al. Enhancing Credibility of Chemical Safety Studies: Emerging Consensus on Key Assessment Criteria , 2010, Environmental health perspectives.
[34] P. Beck‐Peccoz,et al. Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Müllerian derivatives: comparison with normal fetal development. , 2010, Fertility and sterility.
[35] R. Tyl. In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines. , 2010, Birth defects research. Part C, Embryo today : reviews.
[36] J. Jameson,et al. Endocrinology adult and pediatric , 2010 .
[37] Leslie Carol Botha. Body Burden — The Pollution in Newborns , 2010 .
[38] L. Giudice,et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.
[39] I. Quesada,et al. The pancreatic β-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes , 2009, Molecular and Cellular Endocrinology.
[40] Ronald H. White,et al. State-of-the-Science Workshop Report: Issues and Approaches in Low-Dose–Response Extrapolation for Environmental Health Risk Assessment , 2008, Environmental health perspectives.
[41] J. Toppari,et al. Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations. , 2007, International journal of andrology.
[42] DIW Coggon,et al. Time and chance: the stochastic nature of disease causation , 2005, The Lancet.
[43] A. Fourrier-Réglat,et al. Agreement of expert judgment in causality assessment of adverse drug reactions , 2005, European Journal of Clinical Pharmacology.
[44] R. Zoeller,et al. Timing of Thyroid Hormone Action in the Developing Brain: Clinical Observations and Experimental Findings , 2004, Journal of neuroendocrinology.
[45] R. Newbold. Lessons learned from perinatal exposure to diethylstilbestrol. , 2004, Toxicology and applied pharmacology.
[46] J. Franklyn,et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.
[47] William Owens,et al. The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. , 2003, Environmental health perspectives.
[48] Kristina A Thayer,et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.
[49] J. Haseman,et al. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. , 2002, Environmental health perspectives.
[50] Terri Damstra,et al. Global assessment of the state-of-the-science of endocrine disruptors , 2002 .
[51] E. Silbergeld,et al. Organizational and activational effects of estrogenic endocrine disrupting chemicals. , 2002, Cadernos de saude publica.
[52] Wout Slob,et al. Thresholds in Toxicology and Risk Assessment , 1999 .
[53] U. Tillmann,et al. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.
[54] Rosalind,et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.
[55] C. Vionnet. [Environmental health]. , 1983, Krankenpflege. Soins infirmiers.
[56] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.
[57] T. Paine. Common Sense , 1995 .